This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Patel, N. S. Articles by Harris, A. L. Search for Related Content PubMed PubMed Citation Articles by Patel, N. S. Articles by Harris, A. L.

Up-regulation of Delta-like 4 Ligand in Human Tumor Vasculature and the Role of Basal Expression in Endothelial Cell Function

¹ Molecular Oncology Laboratories, Cancer Research UK, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital; ² Department of Urology, Churchill Hospital, University of Oxford, Oxford; and ³ In Situ Hybridization Service, Cancer Research UK, London, United Kingdom

Requests for reprints: Ji-Liang Li, Cancer Research UK, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom. Phone: 44-1865-222457; Fax: 44-1865-222431; E-mail: lij{at}cancer.org.uk or aharris.lab{at}cancer.org.uk.

The Notch signaling pathway and the delta-like 4 ligand (DLL4) play key roles in embryonic vascular development. Many of the pathways involved in embryonic vascular development also play important roles in tumor angiogenesis. In this study, we assessed the expression of DLL4 in primary renal cancer and investigated the biological function of DLL4 in primary endothelial cells. Using real-time quantitative PCR and in situ hybridization, we showed that the expression of DLL4 was up-regulated within the vasculature of clear cell-renal cell carcinoma almost 9-fold more than normal kidney and was correlated with the expression of vascular endothelial growth factor (VEGF). The expression of DLL4 in endothelial cells was up-regulated by VEGF and basic fibroblast growth factor synergistically, and by hypoxia through hypoxia-inducible factor 1. Down-regulation of DLL4 expression with RNA interference led to decreased expression of HEY1 and EphrinB2, and the inhibition of endothelial cell proliferation, migration, and network formation, all of which are important processes in tumor angiogenesis. The inhibition of proliferation occurred via the induction of cell cycle arrest in G₀-G₁ by increased expression of p21 and decreased phosphorylation of retinoblastoma. We conclude that an optimal window of the DLL4 expression is essential for tumor angiogenesis and that selective modulation of the DLL4 expression within human tumors may represent a potential novel antiangiogenic therapy.

This article has been cited by other articles:

				S.-C. Su, E. A. Mendoza, H.-i. Kwak, and K. J. Bayless Molecular profile of endothelial invasion of three-dimensional collagen matrices: insights into angiogenic sprout induction in wound healing Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1215 - C1229. [Abstract] [Full Text] [PDF]

				A. Horowitz and M. Simons Branching Morphogenesis Circ. Res., October 10, 2008; 103(8): 784 - 795. [Abstract] [Full Text] [PDF]

				S. Urs, A. Roudabush, C. F. O'Neill, I. Pinz, I. Prudovsky, D. Kacer, Y. Tang, L. Liaw, and D. Small Soluble Forms of the Notch Ligands Delta1 and Jagged1 Promote in Vivo Tumorigenicity in NIH3T3 Fibroblasts with Distinct Phenotypes Am. J. Pathol., September 1, 2008; 173(3): 865 - 878. [Abstract] [Full Text] [PDF]

				M. Segarra, C. K. Williams, M. d. l. L. Sierra, M. Bernardo, P. J. McCormick, D. Maric, C. Regino, P. Choyke, and G. Tosato Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth Blood, September 1, 2008; 112(5): 1904 - 1911. [Abstract] [Full Text] [PDF]

				Y. Funahashi, S. L. Hernandez, I. Das, A. Ahn, J. Huang, M. Vorontchikhina, A. Sharma, E. Kanamaru, V. Borisenko, D. M. DeSilva, et al. A Notch1 Ectodomain Construct Inhibits Endothelial Notch Signaling, Tumor Growth, and Angiogenesis Cancer Res., June 15, 2008; 68(12): 4727 - 4735. [Abstract] [Full Text] [PDF]

				R. C. A. Sainson, D. A. Johnston, H. C. Chu, M. T. Holderfield, M. N. Nakatsu, S. P. Crampton, J. Davis, E. Conn, and C. C. W. Hughes TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype Blood, May 15, 2008; 111(10): 4997 - 5007. [Abstract] [Full Text] [PDF]

				C. K. Williams, M. Segarra, M. De La Luz Sierra, R. C.A. Sainson, G. Tosato, and A. L. Harris Regulation of CXCR4 by the Notch Ligand Delta-like 4 in Endothelial Cells Cancer Res., March 15, 2008; 68(6): 1889 - 1895. [Abstract] [Full Text] [PDF]

				J. Mazella, S. Liang, and L. Tseng Expression of Delta-Like Protein 4 in the Human Endometrium Endocrinology, January 1, 2008; 149(1): 15 - 19. [Abstract] [Full Text] [PDF]

				M. Yan and G. D. Plowman Delta-like 4/Notch Signaling and Its Therapeutic Implications Clin. Cancer Res., December 15, 2007; 13(24): 7243 - 7246. [Abstract] [Full Text] [PDF]

				J.-L. Li, R. C.A. Sainson, W. Shi, R. Leek, L. S. Harrington, M. Preusser, S. Biswas, H. Turley, E. Heikamp, J. A. Hainfellner, et al. Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivo Cancer Res., December 1, 2007; 67(23): 11244 - 11253. [Abstract] [Full Text] [PDF]

				C. Roca and R. H. Adams Regulation of vascular morphogenesis by Notch signaling Genes & Dev., October 15, 2007; 21(20): 2511 - 2524. [Abstract] [Full Text] [PDF]

				J. Konishi, K. S. Kawaguchi, H. Vo, N. Haruki, A. Gonzalez, D. P. Carbone, and T. P. Dang {gamma}-Secretase Inhibitor Prevents Notch3 Activation and Reduces Proliferation in Human Lung Cancers Cancer Res., September 1, 2007; 67(17): 8051 - 8057. [Abstract] [Full Text] [PDF]

				T. Gridley Notch signaling in vascular development and physiology Development, August 1, 2007; 134(15): 2709 - 2718. [Abstract] [Full Text] [PDF]

				J. D. Leslie, L. Ariza-McNaughton, A. L. Bermange, R. McAdow, S. L. Johnson, and J. Lewis Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis Development, March 1, 2007; 134(5): 839 - 844. [Abstract] [Full Text] [PDF]

				A. Limbourg, M. Ploom, D. Elligsen, I. Sorensen, T. Ziegelhoeffer, A. Gossler, H. Drexler, and F. P. Limbourg Notch Ligand Delta-Like 1 Is Essential for Postnatal Arteriogenesis Circ. Res., February 16, 2007; 100(3): 363 - 371. [Abstract] [Full Text] [PDF]

				D. Generali, S. B. Fox, A. Berruti, J. W. Moore, M. P. Brizzi, N. Patel, G. Allevi, S. Bonardi, S. Aguggini, A. Bersiga, et al. Regulation of Hepatocyte Growth Factor Activator Inhibitor 2 by Hypoxia in Breast Cancer Clin. Cancer Res., January 15, 2007; 13(2): 550 - 558. [Abstract] [Full Text] [PDF]

				C. Cayrol, C. Lacroix, C. Mathe, V. Ecochard, M. Ceribelli, E. Loreau, V. Lazar, P. Dessen, R. Mantovani, L. Aguilar, et al. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes Blood, January 15, 2007; 109(2): 584 - 594. [Abstract] [Full Text] [PDF]

				S. Patiar and A. L Harris Role of hypoxia-inducible factor-1{alpha} as a cancer therapy target Endocr. Relat. Cancer, December 1, 2006; 13(Supplement_1): S61 - S75. [Abstract] [Full Text] [PDF]

				P. Hainaud, J.-O. Contreres, A. Villemain, L.-X. Liu, J. Plouet, G. Tobelem, and E. Dupuy The Role of the Vascular Endothelial Growth Factor-Delta-like 4 Ligand/Notch4-Ephrin B2 Cascade in Tumor Vessel Remodeling and Endothelial Cell Functions. Cancer Res., September 1, 2006; 66(17): 8501 - 8510. [Abstract] [Full Text] [PDF]

				N. S. Patel, M. S. Dobbie, M. Rochester, G. Steers, R. Poulsom, K. Le Monnier, D. W. Cranston, J.-L. Li, and A. L. Harris Up-Regulation of Endothelial Delta-like 4 Expression Correlates with Vessel Maturation in Bladder Cancer. Clin. Cancer Res., August 15, 2006; 12(16): 4836 - 4844. [Abstract] [Full Text] [PDF]